CD14 expression and production by human hepatocytes

Journal of Hepatology

Volumn 31, Issue 3, 1999, Pages 435-442

  Su, Grace L ^a,d   Dorko, Ken ^a   Strom, Stephen C ^a   Nüssler, Andreas K ^b   Wang, Stewart C ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

CD14; Endotoxin; Hepatocyte; Human; Lipopolysaccharide; sCD14

Indexed keywords

CD14 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL STRAIN HL 60; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0033198951     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80034-8     Document Type: Article

References (44)

1. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. [see comments] Science. 249:1990;1431-1433.
2. Tobias PS, Ulevitch RJ. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. [review] Immunobiology. 187:1993;227-232.
3. Ziegler-Heitbrock H, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunology Today. 14:1993;121-125.
4. Dentener MA, Bazil V, Von Asmuth EJ, Ceska M, Buurman W. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol. 150:1993;2885-2891.
5. Martin TR, Mongovin SM, Tobias PS, Mathison JC, Moriarty AM, Leturcq DJ, et al. The CD14 differentiation antigen mediates the development of endotoxin responsiveness during differentiation of mononuclear phagocytes. J Leukoc Biol. 56:1994;1-9.
6. Kielian TL, Blecha F. CD14 and other recognition molecules for lipopolysaccharide: a review. Immunopharmacology. 29:1995;187-205.
7. Haziot A, Tsuberi B, Goyert S. Neutrophil CD14: biochemical properties and role in secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol. 150:1993;5556-5565.
8. Wright SD, Ramos RA, Hermanowski-Vosatka A, Rockwell P, Detmers PA. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med. 173:1991;1281-1286.
9. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci. 90:1993;2744-2748.
10. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med. 176:1992;1665-1671.
11. Haziot A, Rong GW, Silver J, Goyert SM. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol. 151:1993;1500-1507.
12. Haziot A, Rong G-W, Bazil V, Silver J, Goyert SM. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J Immunol. 152:1994;5868-5876.
13. Pugin J, Heumann D, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, et al. CD14 is a pattern recognition receptor. Immunity. 1:1994;509-516.
14. Newman SL, Chaturvedi S, Klein B. The W-1 antigen of blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/DC18 (CR3) and CD14. J Immunol. 154:1995;753-761.
15. Soell M, Lett E, Hoveck F, Scholler M, Wachsmann D, Klein J. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen and mannan binding protein inhibits TNF-alpha release. J Immunol. 154:1995;852-860.
16. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A. Gram positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun. 62:1994;2715-2721.
17. Kusunoki T, Hailman E, Juan TS, Lichenstein HS, Wright SD. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exp Med. 182:1995;1673-1682.
18. Haziot A, Chen E, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol. 141:1988;547-552.
19. Durieux J, Vita N, Octavian P, Guette F, Calzada-Wack J, Munker R, et al. The two soluble forms of lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur J Immunol. 24:1994;2006-2012.
20. Bufler P, Stiegler G, Schuchmann M, Hess S, Kruger C, Stelter F, et al. Soluble lipopolysaccharide receptor (CD14) is release via two different mechanisms from human monocytes and CD14 transfectants. Eur J Immunol. 25:1995;604-610.
21. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol. 147:1991;1567-1574.
22. Fearns C, Kravchenko VV, Ulevitch RJ, Loskutoff DJ. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med. 181:1995;857-866.
23. Dorko K, Freeswick PD, Bartoli F, Cicalese L, Bardsley BA, Tzakis A, et al. A new technique for isolating and culturing human hepatocytes from whole or split livers not used for transplantation. Cell Transplant. 3:1994;387-395.
24. Neussler A, DiSilvio M, Billiar T, Hoffman R, Geller D, Selby R, et al. Stimulation of nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med. 176:1992;271-276.
25. De Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM, et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci. 93:1996;1054-1059.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
27. Su GL, Freeswick PD, Geller DA, Wang Q, Shapiro RA, Wan YH, et al. Molecular cloning, characterization, and tissue distribution of rat lipopolysaccharide binding protein. Evidence for extrahepatic expression. J Immunol. 153:1994;743-752.
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
29. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci. 76:1979;4350-4354.
30. Wang SC, Rossignol DP, Christ WJ, Geller DA, Freeswick PD, Thai NL, et al. Suppression of lipopolysaccahride-induced macrophage nitric oxide and cytokine production in vitro by a novel lipopolysaccharide antagonist. Surgery. 116:1994;339-347.
31. Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood. 73:1989;284-289.
32. Landmann R, Zimmerli W, Sansano S, Link S, Hahn A, Glauser MP, et al. Increased circulating soluble CD14 associated with high mortality in gram-negative septic shock. J Infect Dis. 171:1995;1639-1644.
33. Nockher WA, Bergmann L, Scherberich JE. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol. 98:1994;369-374.
34. Kruger C, Schutt C, Obertacke U, Joka T, Muller FE, Knoller J, et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol. 85:1991;267-301.
35. Labeta MO, Durieux JJ, Fernandez N, Herrmann R, Ferrara P. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol. 23:1993;2144-2151.
36. Bazil V, Baudys M, Hilgert I, Stefanova I, Low MG, Zbrozek J, et al. Structural relationship between the soluble and membrane bound forms of human monocyte surface glycoprotein CD14. Mol Immunol. 26:1989;657-662.
37. Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol. 123:1979;2133-2143.
38. Freudenberg MA, Freudenberg N, Galanos C. Time course of cellular distribution of endotoxin in liver, lungs, and kidneys of rats. Br J Exp Path. 63:1982;56-65.
39. 51Cr-labeled lipopolysaccharide in tissue culture cells and livers of normal mice. Infect Immun. 14:1976;100-105.
40. Parent JB. Membrane receptors on rat hepatocytes for the inner core region of bacterial lipopolysaccharides. J Biol Chem. 265:1990;3455-3461.
41. Mimura Y, Sakisaka S, Harada M, Sata M, Tanikawa K. Role of hepatocyte in direct clearance of lipopolysaccharide in rats. Gastroenterology. 109:1995;1969-1976.
42. Stelter F, Pfister M, Bernheiden M, Jack RS, Bufler P, Engelmann H, et al. The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. Eur J Biochem. 236:1996;457-464.
43. Haziot A, Rong GW, Lin XY, Silver J, Goyert SM. Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J Immunol. 154:1995;6529-6532.
44. Troelstra A, Giepmans BNG, Van Kessel KPM, Lichenstein HS, Verrhoef J, Ban Strijp JAG. Dual effects of soluble CD14 on LPS priming of neutrophils. J Leukoc Biol. 61:1997;173-178.